News

Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018

November 15, 2018

DCCR treatment resulted in statistically significant decreases in body fat in subjects with Prader-Willi Syndrome ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results

November 15, 2018

REDWOOD CITY, Calif. , Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference

October 08, 2018

Oral presentation on DCCR’s mechanism of action in treating hyperphagia Poster presentation on DCCR’...

Read More
Soleno – Home